Florence Wong
About
In The Last Decade
Florence Wong
240 papers receiving 13.0k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hepatology 11.2k
- Epidemiology 9.0k
- Surgery 5.2k
- Nephrology 1.8k
- Pulmonary and Respiratory Medicine 1.5k
Countries citing papers authored by Florence Wong
This map shows the geographic impact of Florence Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Wong more than expected).
Fields of papers citing papers by Florence Wong
This network shows the impact of papers produced by Florence Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Wong. The network helps show where Florence Wong may publish in the future.
Co-authorship network of co-authors of Florence Wong
This figure shows the co-authorship network connecting the top 25 collaborators of Florence Wong. A scholar is included among the top collaborators of Florence Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Wong. Florence Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 13 | |
| 7 | 36 | |
| 8 | 81 | |
| 9 | 17 | |
| 10 | 9 | |
| 11 | 150 | |
| 12 | Verified Hepatorenal Syndrome Reversal As A Robust Multi-Component Primary End Point: The CONFIRM Study Trial Design | 1 |
| 13 | Diagnosing and treating renal disease in cirrhotic patients. | 7 |
| 14 | Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites breakdown → | 559 |
| 15 | Effects of a selective vasopressin V2 receptor antagonist, satavaptan (SR121463B), on recurrence of ascites after large volume paracentesis | 10 |
| 16 | Phase Iib Extended-Treatment Trial of Telbivudine (LdT) Vs Lamivudine Vs Combination Treatment in Hepatitis B Patients: Two-Year Results | 12 |
| 17 | 200 | |
| 18 | 223 | |
| 19 | 2 | |
| 20 | 30 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.